2021

1. Modulation of intratumoural myeloid cells, the hallmark of the anti-tumour efficacy induced by a triple combination: tumour-associated peptide, TLR-3 ligand and α-PD-1

   British Journal of Cancer, Vol. 124, Núm. 7, pp. 1275-1285